Hsing-Ting Yu

1.2k total citations
17 papers, 968 citations indexed

About

Hsing-Ting Yu is a scholar working on Infectious Diseases, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hsing-Ting Yu has authored 17 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hsing-Ting Yu's work include Venous Thromboembolism Diagnosis and Management (3 papers), Antifungal resistance and susceptibility (2 papers) and Healthcare cost, quality, practices (2 papers). Hsing-Ting Yu is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), Antifungal resistance and susceptibility (2 papers) and Healthcare cost, quality, practices (2 papers). Hsing-Ting Yu collaborates with scholars based in United States, United Kingdom and China. Hsing-Ting Yu's co-authors include Jay Lin, Robert W. Dubois, Michelle Dylan, Allen R. Nissenson, Alisa Wilson, Lawrence T. Goodnough, Chiun‐Fang Chiou, Peter J. Neumann, Joel W. Hay and Emmett B. Keeler and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and Critical Care Medicine.

In The Last Decade

Hsing-Ting Yu

17 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hsing-Ting Yu United States	12	273	226	177	176	106	17	968
Gregory Brill United States	21	285 1.0×	98 0.4×	111 0.6×	258 1.5×	109 1.0×	54	1.2k
Lucie Opatrny Canada	14	190 0.7×	76 0.3×	158 0.9×	63 0.4×	45 0.4×	28	938
Gang Fang United States	20	408 1.5×	113 0.5×	111 0.6×	212 1.2×	80 0.8×	38	961
Géric Maura France	14	444 1.6×	185 0.8×	138 0.8×	127 0.7×	210 2.0×	28	1.2k
J. Michael Paterson Canada	19	178 0.7×	62 0.3×	512 2.9×	142 0.8×	241 2.3×	48	1.5k
Sandra Kruchov Thygesen Denmark	7	320 1.2×	70 0.3×	239 1.4×	55 0.3×	269 2.5×	8	1.1k
Rasha Khatib United States	17	793 2.9×	316 1.4×	223 1.3×	150 0.9×	385 3.6×	45	1.7k
Lianne Parkin New Zealand	14	154 0.6×	139 0.6×	166 0.9×	51 0.3×	44 0.4×	47	823
Trine Frøslev Denmark	18	557 2.0×	118 0.5×	364 2.1×	69 0.4×	351 3.3×	47	1.6k
Pierre‐Olivier Blotière France	14	255 0.9×	119 0.5×	187 1.1×	82 0.5×	209 2.0×	23	1.1k

Countries citing papers authored by Hsing-Ting Yu

Since Specialization

Citations

This map shows the geographic impact of Hsing-Ting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing-Ting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing-Ting Yu more than expected).

Fields of papers citing papers by Hsing-Ting Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsing-Ting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing-Ting Yu. The network helps show where Hsing-Ting Yu may publish in the future.

Co-authorship network of co-authors of Hsing-Ting Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsing-Ting Yu. A scholar is included among the top collaborators of Hsing-Ting Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsing-Ting Yu. Hsing-Ting Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kish, Jonathan, et al.. (2020). Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States. Advances in Therapy. 37(6). 2841–2852. 30 indexed citations

Klink, Andrew J., Bruce A. Feinberg, Hsing-Ting Yu, et al.. (2019). Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors. The Oncologist. 24(10). 1331–1339. 11 indexed citations

Feinberg, Bruce A., et al.. (2018). Real-world dosing patterns among metastatic breast cancer patients initiating first line (1L) palbociclib (PAL) therapy.. Journal of Clinical Oncology. 36(15_suppl). e13050–e13050. 1 indexed citations

Dean, Bonnie B., et al.. (2014). Computerized Clinical Decision Support to Prevent Venous Thromboembolism Among Hospitalized Patients. Journal for Healthcare Quality. 37(4). 221–231. 26 indexed citations

Ko, Kelly J., Rolin L. Wade, Hsing-Ting Yu, et al.. (2014). Implementation of a Pharmacy-Based Adult Vaccine Benefit: Recommendations for a Commercial Health Plan Benefit. Journal of Managed Care Pharmacy. 20(3). 273–282. 16 indexed citations

Zilberberg, Marya D., et al.. (2014). Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Critical Care. 18(5). 590–590. 11 indexed citations

Wade, Rolin L., et al.. (2012). 847. Critical Care Medicine. 40. 1–328. 1 indexed citations

Lee, Lauren J., Matthew F Emons, Sherry Martin, et al.. (2012). Association of blood glucose levels with in-hospital mortality and 30-day readmission in patients undergoing invasive cardiovascular surgery. Current Medical Research and Opinion. 28(10). 1657–1665. 6 indexed citations

Emons, Matthew F, Bonnie B. Dean, Hsing-Ting Yu, et al.. (2011). PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice. Value in Health. 14(7). A435–A435. 2 indexed citations

10.

Zimetbaum, Peter, Amit J. Thosani, Hsing-Ting Yu, et al.. (2010). Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?. The American Journal of Medicine. 123(5). 446–453. 119 indexed citations

11.

Dean, Bonnie B., Hsing-Ting Yu, Jay Bae, et al.. (2010). Pattern of clopidogrel use in hospitalized patients receiving percutaneous coronary interventions. American Journal of Health-System Pharmacy. 67(17). 1430–1437. 12 indexed citations

12.

Dubois, Robert W., Daniel Aguilar, Ronnie Fass, et al.. (2007). Consequences of frequent nocturnal gastro‐oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Alimentary Pharmacology & Therapeutics. 25(4). 487–500. 82 indexed citations

13.

Danese, Mark D., Robert I. Griffiths, Michelle Dylan, et al.. (2006). Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodialysis International. 10(1). 56–62. 40 indexed citations

14.

Yu, Hsing-Ting, Michelle Dylan, Jay Lin, & Robert W. Dubois. (2006). Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. American Journal of Health-System Pharmacy. 64(1). 69–76. 163 indexed citations

15.

Wilson, Alisa, Hsing-Ting Yu, Lawrence T. Goodnough, & Allen R. Nissenson. (2004). Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. The American Journal of Medicine. 116(7). 50–57. 159 indexed citations

16.

Chiou, Chiun‐Fang, Joel W. Hay, Joel Wallace, et al.. (2003). Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies. Medical Care. 41(1). 32–44. 248 indexed citations

17.

Borenstein, Jeff, Hsing-Ting Yu, Sally Wade, Chiun‐Fang Chiou, & Andrea J. Rapkin. (2003). Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.. PubMed. 48(2). 79–85. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact